FAST NEWS: Simcere Pharma Surges After Applying for New Drug Clinical Trials
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) said on Thursday its self-developed anti-tumor drug candidates SIM0237 and SIM0348 were accepted by the Center For Drug Evaluation of China’s National Medical…
FAST NEWS: Connect Biopharma Plunges Despite Positive Drug Trial Results
The latest: Connect Biopharma (CNTB.US) said on Tuesday its CBP-201 drug candidate achieved all primary and key secondary endpoints in the primary analysis population for a 16-week pivotal trial of…
FAST NEWS: Legend Biotech Terminates New Drug Trial Lacking Clinical Benefit
The latest: Legend Biotech Corp. (LEGN.US), a cell therapy subsidiary of Genscript Biotech Corp. (1548.HK), has terminated its Phase 1 Clinical Trial under the Investigational New Drug (IND) application for LB1901, due to…
FAST NEWS: Ascletis Pharma’s Cancer Drug Eyes U.S. with New Drug Application
The latest: Ascletis Pharma Inc. (1672.HK) announced it has filed an Investigational New Drug (IND) application in the U.S. for its self-house developed oral PD-L1 small molecule inhibitor, ASC61, for the…
FAST NEWS: Kintor Pharma Plunges after Covid-19 Drug Fails Clinical Trial
The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced that an interim analysis of data from a multi-regional Phase III clinical trial for its oral drug proxalutamide to treat Covid-19 did not…
Recent Articles
RELATED ARTICLES
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK -
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Clinical trials come up short again for Alphamab Oncology
9966.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
